Tamoxifen Citrate 98.0%(HPLC)
98.0%(HPLC)
Properties
| Water Solubility | Slightly Soluble |
| Assay Purity | >98%(HPLC) |
| B pt. | 665.9℃ at 760 mmHg |
| M pt. | 142℃(dec.) |
Safety Information
| Hazard Statement(s) | H302 - H350 - H360D - H410 |
| Precautionary Statement | P201 - P273 - P301 + P312 + P330 - P308 + P313 |
| Symbol |
|
| Signal word | Danger |
| HS Code | 2922199090 |
| Flash point | 356.5℃ |
| Storage Temp. | 2-8℃ |
| Packaging | Glass bottle |
Description
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Tamoxifen Citrate is a selective estrogen response modifier (SERM) protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |